Chun-Tse Hung

Dr. Chun-Tse Hung

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 April 2025 in The Journal of Allergy and Clinical Immunology: In Practice
Verified
Journal Article
Closed access
CHChun-Tse Hung
Chun-Tse Hung
YHYu-Chien Hung
Yu-Chien Hung
CSChi-Won Suk
Chi-Won Suk

16 January 2024 in Journal of Asthma
Verified
Journal Article
Closed access
CHChun-Tse Hung
Chun-Tse Hung
YHYu-Chien Hung
Yu-Chien Hung
CSChi-Won Suk
Chi-Won Suk
The purpose of this study was to assess: (1) the prevalence of long COVID by asthma status, and (2) the characteristics associated with developing long COVID among adults with asthma in the United States. Data from the 2022 National Health Interview Survey were used. The prevalence of long COVID was reported and stratified by asthma status. The multivariable logistic regression model was conducted to identify the factors associated with developing long COVID. In 2022, the overall prevalence of long COVID among U.S. adults was 6.9%. When stratified by asthma status, the prevalence of long COVID was 13.9% among adults with asthma, and 6.2% among adults without asthma. Among adults with asthma, certain characteristics, including age over 55 years, female sex, obesity, problems paying medical bills and a history of asthma attacks, were significantly associated with developing long COVID. This study revealed that the prevalence of long COVID among adults with asthma was much higher than the general adult population in the United States. The limited validity of the collected information in this study should prompt caution when interpreting our findings. Further studies on the association between asthma and long COVID could be valuable for the clinical practice.

9 December 2024 in Thorax
Verified
Journal Article
Open access
PDF file
CHChun-Tse Hung
Chun-Tse Hung
SESteven R Erickson
Steven R Erickson
CWChung-Hsuen Wu
Chung-Hsuen Wu
Background Uncontrolled asthma is possibly caused by medication non-adherence, and financial hardship can be a major contributor to non-adherence. Since economic conditions and asthma management have changed over time, a comprehensive investigation of cost-related medication non-adherence (CRN) among adults with asthma is crucial. Objective To evaluate trends, prevalence and determinants of CRN, and its impact on asthma control among US adults with asthma. Methods Data from 2011 to 2022 National Health Interview Survey were used. Joinpoint regression analysis was used to evaluate trends in the prevalence of CRN. A multivariable logistic regression model was used to identify factors associated with CRN. Two additional multivariable logistic regression models were used to examine associations between CRN and asthma-related adverse events, including asthma attacks and emergency room (ER) visits for asthma. Results A total of 30 793 adults with asthma were included, representing 8.1% (19.38 million) of the US population. From 2011 to 2022, a declining trend in the prevalence of CRN among US adults with asthma was observed. Approximately every one in six adults with asthma was non-adherent to medications due to cost. Several factors, including demographics and comorbidities, were associated with CRN. Adults with asthma who had CRN were at an increased risk of experiencing asthma attacks (adjusted OR, 1.95; 95% CI 1.78 to 2.13) and ER visits for asthma (adjusted OR, 1.63; 95% CI 1.44 to 1.84). Conclusion Since asthma is one of the leading chronic diseases, the burden of cost-related non-adherence to medications highlights the need for appropriate policies and social supports to address such problems.

2 July 2024 in Journal of the American Pharmacists Association
Verified
Journal Article
Closed access
CHChun-Tse Hung
Chun-Tse Hung
YHYu-Chien Hung
Yu-Chien Hung
CSChi-Won Suk
Chi-Won Suk
DLDing-Cheng Liu
Ding-Cheng Liu

28 May 2025 in Vaccine
Verified
Journal Article
Closed access
CHChun-Tse Hung
Chun-Tse Hung
LWLi-Min Wang
Li-Min Wang
DLDing-Cheng Liu
Ding-Cheng Liu

12 December 2025 in Pharmacoepidemiology and Drug Safety
Verified
Journal Article
Open access
CHChun-Tse Hung
Chun-Tse Hung
LWLi‐Min Wang
Li‐Min Wang
DLDing‐Cheng Liu
Ding‐Cheng Liu
YHYu‐Chien Hung
Yu‐Chien Hung
Purpose: To evaluate trends and disparities in herpes zoster vaccination among US older adults with diabetes. Methods: Data from the 2008 to 2023 National Health Interview Survey were used. Joinpoint regression analysis was performed to analyze trends in herpes zoster vaccination. A multivariable logistic regression model was used to identify factors associated with herpes zoster vaccination. Results: A total of 42 377 participants with diabetes were included, representing approximately 18 million US older adults with diabetes. From 2008 to 2023, the prevalence of herpes zoster vaccination increased nearly tenfold, from 4.2% in 2008 to 42.2% in 2023 (average annual percent change = 14.09, p < 0.01), with similar overall trends observed in adults without diabetes ( p = 0.08). Upward trends were also observed across age groups and diabetes types. Several factors, including age, race/ethnicity, region, educational level, health insurance, income, perceived health status, flu and pneumococcal vaccination, comorbid atherosclerotic cardiovascular disease and cancer, were associated with herpes zoster vaccination. Conclusion: Herpes zoster vaccine coverage has surged among US older adults with diabetes over the past 16 years. However, disparities in vaccination remain, underscoring the need for targeted policies and interventions to improve coverage.